|
|
Volumn 333, Issue 6041, 2011, Pages 393-
|
|
Complexity surrounds HIV prevention advances
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
EMTRICITABINE PLUS TENOFOVIR DISOPROXIL;
PLACEBO;
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
DEOXYCYTIDINE;
DRUG DERIVATIVE;
ORGANOPHOSPHORUS COMPOUND;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
COMPLEXITY;
DISEASE TRANSMISSION;
DRUG;
HUMAN IMMUNODEFICIENCY VIRUS;
INFECTIVITY;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
CONDOM;
COUNSELING;
DISEASE TRANSMISSION;
HEALTH CARE COST;
HETEROSEXUAL FEMALE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INCOME;
INFECTION PREVENTION;
MALE HOMOSEXUAL;
PREVENTIVE MEDICINE;
PRIORITY JOURNAL;
RISK ASSESSMENT;
SEXUALLY TRANSMITTED DISEASE;
SHORT SURVEY;
CLINICAL TRIAL (TOPIC);
DRUG COMBINATION;
DRUG COST;
ECONOMICS;
FEMALE;
MALE;
NOTE;
PATIENT COMPLIANCE;
ANTI-HIV AGENTS;
CLINICAL TRIALS AS TOPIC;
DEOXYCYTIDINE;
DRUG COMBINATIONS;
DRUG COSTS;
FEMALE;
HIV INFECTIONS;
HUMANS;
MALE;
MEDICATION ADHERENCE;
ORGANOPHOSPHORUS COMPOUNDS;
|
|
EID: 84855749953
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.333.6041.393 Document Type: Short Survey |
|
Times cited : (6)
|
|
References (0)
|
